Article thumbnail

P17.04 * RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP

By C. Balana, R. d. l. Penas, J. Sepulveda, M. G. Gil, R. Luque, O. Gallego, G. Reynes, A. Herrero, P. Perez-Segura and A. Berrocal
Publisher: Oxford University Press (OUP)
Year: 2014
DOI identifier: 10.1093/neuonc/nou174.334
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://europepmc.org/articles/... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.